The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Quantitative Evaluation of Drug or Device Effects on Ventricular Remodeling as Predictors of Therapeutic Effects on Mortality in Patients With Heart Failure and Reduced Ejection Fraction
Open accessAbstract
Objectives The purpose of this study was to quantitatively assess the relationship between therapy-induced changes in left ventricular (LV) remodeling and longer-term outcomes in patients with left ventricular dysfunction (LVD). Background Whether therapy-induced changes in left ventricular ejection fraction (LVEF), end-diastolic volume (EDV), and end-systolic volume (ESV) are predictors of mortality in patients with LVD is not established. Methods Searches for randomized controlled trials (RCTs) were conducted to identify drug or device therapies for which an effect on mortality in patients with LVD was studied in at least 1 RCT of ≥500 patients (mortality trials). Then, all RCTs involving those therapies were identified in patients with LVD that described changes in LVEF and/or volumes over time (remodeling trials). We examined whether the magnitude of remodeling effects is associated with the odds ratios for death across all therapies or associated with whether the odds ratio for mortality was favorable, neutral, or adverse (i.e., statistically significantly decreased, nonsignificant, or statistically significantly increased odds for mortality, respectively). Results Included were 30 mortality trials of 25 drug/device therapies (n = 69,766 patients; median follow-up 17 months) and 88 remodeling trials of the same therapies (n = 19,921 patients; median follow-up 6 months). The odds ratio for death in the mortality trials was correlated with drug/device effects on LVEF (r = −0.51, p < 0.001), EDV (r = 0.44, p = 0.002), and ESV (r = 0.48, p = 0.002). In (ordinal) logistic regressions, the odds for neutral or favorable effects in the mortality RCTs increased with mean increases in LVEF and with mean decreases in EDV and ESV in the remodeling trials. Conclusions In patients with LVD, short-term trial-level therapeutic effects of a drug or device on LV remodeling are associated with longer-term trial-level effects on mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
Cleland, J. G. F., Daubert, J.-C., Erdmann, E., Freemantle, N., Gras, D., Kappenberger, L., & Tavazzi, L. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050496 · Cited by 6,276
Mathematical Methods of Statistics.
Geary, R. C., & Cramer, H. (1947) · The Economic Journal · doi:10.2307/2226151 · Cited by 5,927
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial
(1999) · The Lancet · doi:10.1016/s0140-6736(98)11181-9 · Cited by 4,929
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
Packer, M., Bristow, M. R., Cohn, J. N., Colucci, W. S., Fowler, M. B., Gilbert, E. M., & Shusterman, N. H. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342101 · Cited by 4,649
(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725
The Handbook of Research Synthesis.
Howel, D., Cooper, H., & Hedges, L. V. (1995) · Biometrics · doi:10.2307/2533295 · Cited by 3,642
Simplified calculation of body surface area
(1987) · New England Journal of Medicine · doi:10.1056/nejm198710223171717 · Cited by 3,238
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
Cohn, J. N., & Tognoni, G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010713 · Cited by 3,108
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., Fowler, M. B., Katus, H. A., Krum, H., Mohacsi, P., Rouleau, J. L., Tendera, M., Castaigne, A., Roecker, E. B., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442201 · Cited by 3,093
The effect of digoxin on mortality and morbidity in patients with heart failure
(1997) · New England Journal of Medicine · doi:10.1056/nejm199702203360801 · Cited by 3,016
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
PITT, B., ZANNAD, F., REMME, W. J., CODY, R., CASTAIGNE, A., PEREZ, A., PALENSKY, J., & WITTES, J. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200006000-00059 · Cited by 2,927
McMurray, J. J., Östergren, J., Swedberg, K., Granger, C. B., Held, P., Michelson, E. L., Olofsson, B., Yusuf, S., & Pfeffer, M. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14283-3 · Cited by 2,604
Teichholz, L. E., Kreulen, T., Herman, M. V., & Gorlin, R. (1976) · The American Journal of Cardiology · doi:10.1016/0002-9149(76)90491-4 · Cited by 2,571
Quantitative Synthesis in Systematic Reviews
Lau, J., Ioannidis, J. P. A., & Schmid, C. H. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-9-199711010-00008 · Cited by 2,517 · cited 1×
“10) (31) and calculated its ext ent with I(2) (32).”
BackgroundEffect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
Cohn, J. N., Archibald, D. G., Ziesche, S., Franciosa, J. A., Harston, W. E., Tristani, F. E., Dunkman, W. B., Jacobs, W., Francis, G. S., Flohr, K. H., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606123142404 · Cited by 2,400
White, H. D., Norris, R. M., Brown, M. A., Brandt, P. W., Whitlock, R. M., & Wild, C. J. (1987) · Circulation · doi:10.1161/01.cir.76.1.44 · Cited by 2,363
Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
Packer, M., Carver, J. R., Rodeheffer, R. J., Ivanhoe, R. J., DiBianco, R., Zeldis, S. M., Hendrix, G. H., Bommer, W. J., Elkayam, U., Kukin, M. L., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111213252103 · Cited by 2,225
Cohn, J. N., Ferrari, R., & Sharpe, N. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00630-0 · Cited by 2,161
Surrogate endpoints in clinical trials: Definition and operational criteria
Prentice, R. L. (1989) · Statistics in Medicine · doi:10.1002/sim.4780080407 · Cited by 2,057
Parametric measures of effect size.
Rosenthal, R. (1994) · Cited by 1,847
Left Ventricular Remodeling After Myocardial Infarction: Pathophysiology and Therapy
Sutton, M. G. S. J., & Sharpe, N. (2000) · Circulation · doi:10.1161/01.cir.101.25.2981 · Cited by 1,824
Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure
Taylor, A. L., Ziesche, S., Yancy, C., Carson, P., D'Agostino, R., Ferdinand, K., Taylor, M., Adams, K., Sabolinski, M., Worcel, M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042934 · Cited by 1,773
Granger, C. B., McMurray, J. J., Yusuf, S., Held, P., Michelson, E. L., Olofsson, B., Östergren, J., Pfeffer, M. A., & Swedberg, K. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14284-5 · Cited by 1,686
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., & Fowler, M. B. (2001) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00477-9 · Cited by 1,661
Surrogate End Points in Clinical Trials: Are We Being Misled?
Fleming, T. R., & DeMets, D. L. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-7-199610010-00011 · Cited by 1,651
Konstam, M. A. (2007) · JAMA · doi:10.1001/jama.297.12.1319 · Cited by 1,628
Self-citationHjalmarson, Å., Goldstein, S., Fagerberg, B., Wedel, H., Waagstein, F., Kjekshus, J., Wikstrand, J., El Allaf, D., Vítovec, J., Aldershvile, J., et al. (2000) · JAMA · doi:10.1001/jama.283.10.1295 · Cited by 1,399
Bristow, M. R., Gilbert, E. M., Abraham, W. T., Adams, K. F., Fowler, M. B., Hershberger, R. E., Kubo, S. H., Narahara, K. A., Ingersoll, H., Krueger, S., et al. (1996) · Circulation · doi:10.1161/01.cir.94.11.2807 · Cited by 1,303
Mann, D. L., McMurray, J. J. V., Packer, M., Swedberg, K., Borer, J. S., Colucci, W. S., Djian, J., Drexler, H., Feldman, A., Kober, L., et al. (2004) · Circulation · doi:10.1161/01.cir.0000124490.27666.b2 · Cited by 1,240
Amiodarone in Patients with Congestive Heart Failure and Asymptomatic Ventricular Arrhythmia
Singh, S. N., Fletcher, R. D., Fisher, S. G., Singh, B. N., Lewis, H. D., Deedwania, P. C., Massie, B. M., Colling, C., & Lazzeri, D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507133330201 · Cited by 1,225
Effect of Amlodipine on Morbidity and Mortality in Severe Chronic Heart Failure
Packer, M., O'Connor, C. M., Ghali, J. K., Pressler, M. L., Carson, P. E., Belkin, R. N., Miller, A. B., Neuberg, G. W., Frid, D., Wertheimer, J. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610103351504 · Cited by 1,196
St John Sutton, M. G., Plappert, T., Abraham, W. T., Smith, A. L., DeLurgio, D. B., Leon, A. R., Loh, E., Kocovic, D. Z., Fisher, W. G., Ellestad, M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000065226.24159.e9 · Cited by 1,124
Effect of Captopril on Progressive Ventricular Dilatation after Anterior Myocardial Infarction
Pfeffer, M. A., Lamas, G. A., Vaughan, D. E., Parisi, A. F., & Braunwald, E. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807143190204 · Cited by 1,103
McMurray, J. J. V., Östergren, J., Swedberg, K. B., Granger, C. B., Held, P., Michelson, E. L., Olofsson, B., Yusuf, S., & Pfeffer (2003) · The Lancet · Cited by 1,043
A Trial of the Beta-Blocker Bucindolol in Patients with Advanced Chronic Heart Failure
(2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442202 · Cited by 1,007
Packer, M., Gheorghiade, M., Young, J. B., Costantini, P. J., Adams, K. F., Cody, R. J., Smith, L. K., Van Voorhees, L., Gourley, L. A., & Jolly, M. K. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307013290101 · Cited by 827
Mean body weight, height, and body mass index, United States 1960-2002.
Ogden, C. L., Fryar, C. D., Carroll, M. D., & Flegal, K. M. (2004) · PubMed · Cited by 717
Higgins, S. L., Hummel, J. D., Niazi, I. K., Giudici, M. C., Worley, S. J., Saxon, L. A., Boehmer, J. P., Higginbotham, M. B., De Marco, T., Foster, E., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)01042-8 · Cited by 712
(1993) · New England Journal of Medicine · doi:10.1056/nejm199312093292417 · Cited by 639
Carvedilol Inhibits Clinical Progression in Patients With Mild Symptoms of Heart Failure
Colucci, W. S., Packer, M., Bristow, M. R., Gilbert, E. M., Cohn, J. N., Fowler, M. B., Krueger, S. K., Hershberger, R., Uretsky, B. F., Bowers, J. A., et al. (1996) · Circulation · doi:10.1161/01.cir.94.11.2800 · Cited by 635
Packer, M., Califf, R. M., Konstam, M. A., Krum, H., McMurray, J. J., Rouleau, J.-L., & Swedberg, K. (2002) · Circulation · doi:10.1161/01.cir.0000029801.86489.50 · Cited by 621
Self-citationPacker, M., Colucci, W. S., Sackner-Bernstein, J. D., Liang, C.-S., Goldscher, D. A., Freeman, I., Kukin, M. L., Kinhal, V., Udelson, J. E., Klapholz, M., et al. (1996) · Circulation · doi:10.1161/01.cir.94.11.2793 · Cited by 613
Self-citationKonstam, M. A., Rousseau, M. F., Kronenberg, M. W., Udelson, J. E., Melin, J., Stewart, D., Dolan, N., Edens, T. R., Ahn, S., & Kinan, D. (1992) · Circulation · doi:10.1161/01.cir.86.2.431 · Cited by 601
Self-citationA placebo-controlled trial of captopril in refractory chronic congestive heart failure
(1983) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(83)80316-7 · Cited by 589
Uretsky, B. F., Young, J. B., Shahidi, F. E., Yellen, L. G., Harrison, M. C., & Jolly, M. K. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90403-n · Cited by 582
Cohn, J. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03720040031022 · Cited by 582
Abraham, W. T., Young, J. B., León, A. R., Adler, S., Bank, A. J., Hall, S. A., Lieberman, R., Liem, L. B., O’Connell, J. B., Schroeder, J. S., et al. (2004) · Circulation · doi:10.1161/01.cir.0000146336.92331.d1 · Cited by 559
DiBianco, R., Shabetai, R., Kostuk, W., Moran, J., Schlant, R. C., & Wright, R. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903163201101 · Cited by 550
Sanz, G., Castañer, A., Betriu, A., Magriña, J., Roig, E., Coll, S., Paré, J. C., & Navarro-López, F. (1982) · New England Journal of Medicine · doi:10.1056/nejm198205063061801 · Cited by 529
TREATMENT OF PATIENTS WITH SYMPTOMLESS LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION
Sharpe, N., Smith, H., Murphy, J., & Hannan, S. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90347-9 · Cited by 481
Greenberg, B., Quinones, M. A., Koilpillai, C., Limacher, M., Shindler, D., Benedict, C., & Shelton, B. (1995) · Circulation · doi:10.1161/01.cir.91.10.2573 · Cited by 473
Doughty, R. N., Whalley, G. A., Gamble, G., MacMahon, S., & Sharpe, N. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00012-0 · Cited by 422
Taylor, G. J., Humphries, J. O., Mellits, E. D., et al. (1980) · Circulation · doi:10.1161/01.cir.62.5.960 · Cited by 408
Rouleau, J. L., Pfeffer, M. A., Stewart, D. J., Isaac, D., Sestier, F., Kerut, E. K., Porter, C. B., Proulx, G., Qian, C., & Block, A. J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02602-7 · Cited by 396
Bozkurt, B., Torre-Amione, G., Warren, M. S., Whitmore, J., Soran, O. Z., Feldman, A. M., & Mann, D. L. (2001) · Circulation · doi:10.1161/01.cir.103.8.1044 · Cited by 388
Cohn, J. N., Pfeffer, M. A., Rouleau, J., Sharpe, N., Swedberg, K., Straub, M., Wiltse, C., Wright, T. J., & for the MOXCON Investigators (2003) · European Journal of Heart Failure · doi:10.1016/s1388-9842(03)00163-6 · Cited by 384
Krum, H., Sackner-Bernstein, J. D., Goldsmith, R. L., Kukin, M. L., Schwartz, B., Penn, J., Medina, N., Yushak, M., Horn, E., Katz, S. D., et al. (1995) · Circulation · doi:10.1161/01.cir.92.6.1499 · Cited by 374
Olsen, S. L., Gilbert, E. M., Renlund, D. G., Taylor, D. O., Yanowitz, F. D., & Bristow, M. R. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00012-s · Cited by 373
Tsutamoto, T., Wada, A., Maeda, K., Mabuchi, N., Hayashi, M., Tsutsui, T., Ohnishi, M., Sawaki, M., Fujii, M., Matsumoto, T., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01116-0 · Cited by 363
Meta-analysis for the evaluation of potential surrogate markers
Daniels, M. J., & Hughes, M. D. (1997) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19970915)16:17<1965::aid-sim630>3.0.co;2-m · Cited by 362
Bucher, H. C., Guyatt, G. H., Cook, D. J., Holbrook, A., McAlister, F. A., & for the Evidence-Based Medicine Working Group (1999) · JAMA · doi:10.1001/jama.282.8.771 · Cited by 361
Cohn, J. N., Ziesche, S., Smith, R., Anand, I., Dunkman, W. B., Loeb, H., Cintron, G., Boden, W., Baruch, L., Rochin, P., et al. (1997) · Circulation · doi:10.1161/01.cir.96.3.856 · Cited by 358
Anand, I., McMurray, J., Cohn, J. N., Konstam, M. A., Notter, T., Quitzau, K., Ruschitzka, F., & Lüscher, T. F. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16723-8 · Cited by 347
Self-citationMetra, M., Nardi, M., Giubbini, R., & Cas, L. D. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90174-0 · Cited by 320
Lowes, B. D., Gill, E. A., Abraham, W. T., Larrain, J.-R., Robertson, A. D., Bristow, M. R., & Gilbert, E. M. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00059-4 · Cited by 318
Barr, C. S., Lang, C. C., Hanson, J., Arnott, M., Kennedy, N., & Struthers, A. D. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80353-1 · Cited by 318
Konstam, M. A., Kronenberg, M. W., Rousseau, M. F., Udelson, J. E., Melin, J., Stewart, D., Dolan, N., Edens, T. R., Ahn, S., & Kinan, D. (1993) · Circulation · doi:10.1161/01.cir.88.5.2277 · Cited by 316 · cited 1×
“Some published studies indeed eport such results (20,21,45), although the vast majority of emodeling studies do not.”
BackgroundSelf-citationCleland, J., Pennell, D., Ray, S., Coats, A., Macfarlane, P., Murray, G., Mule, J. D., Vered, Z., & Lahiri, A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13801-9 · Cited by 301
Kalra, P. R., Moon, J. C. C., & Coats, A. J. S. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00182-1 · Cited by 293
Saxon, L. A., De Marco, T., Schafer, J., Chatterjee, K., Kumar, U. N., & Foster, E. (2002) · Circulation · doi:10.1161/hc1102.105730 · Cited by 292
Groenning, B. A., Nilsson, J. C., Sondergaard, L., Fritz-Hansen, T., Larsson, H. B. W., & Hildebrandt, P. R. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01006-8 · Cited by 288
HJALMARSON, A., FAGERBERG, S. G. B., WREDEL, H., WAAGSTEIN, F., KJEKSHUS, J., WIKSTRAND, J., EL ALLAF, D., VÍTOVEC, J., ALDERSHIVILE, J., HALINEN, M., et al. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200012000-00023 · Cited by 282
Bristow, M. R., O'Connell, J. B., Gilbert, E. M., French, W. J., Leatherman, G., Kantrowitz, N. E., Orie, J., Smucker, M. L., Marshall, G., & Kelly, P. (1994) · Circulation · doi:10.1161/01.cir.89.4.1632 · Cited by 272
Cintrón, G., Johnson, G. A., FRANCIS, G. S., Cobb, F. R., & Cohn, J. N. (1993) · Circulation · Cited by 267
Prognosis of congestive heart failure and predictors of mortality
Cohn, J. N., & Rector, T. S. (1988) · The American Journal of Cardiology · doi:10.1016/s0002-9149(88)80081-x · Cited by 263
Keogh, A. M., Baron, D. W., & Hickie, J. B. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)91434-8 · Cited by 261
Cintrón, G., Johnson, G., FRANCIS, G. S., Cobb, F. R., & Jn, C. (1993) · PubMed · Cited by 257
Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure
Hampton, Jr., van Veldhuisen, D., Kleber, F., Cowley, A., Ardia, A., Block, P., Cortina, A., Cserhalmi, L., Follath, F., Jensen, G., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(96)10488-8 · Cited by 256
Wong, M., Staszewsky, L., Latini, R., Barlera, S., Volpi, A., Chiang, Y.-T., Benza, R. L., Gottlieb, S. O., Kleemann, T. D., Rosconi, F., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02063-6 · Cited by 245
Miles, B. E., Attwood, E. C., & Seddon, R. M. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91383-0 · Cited by 236
Woodley, S. L., Gilbert, E. M., Anderson, J. L., O'Connell, J. B., Deitchman, D., Yanowitz, F. G., Mealey, P. C., Volkman, K., Renlund, D. G., & Menlove, R. (1991) · Circulation · doi:10.1161/01.cir.84.6.2426 · Cited by 223
Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure
Wong, M., Staszewsky, L., Latini, R., Barlera, S., Glazer, R., Aknay, N., Hester, A., Anand, I., & Cohn, J. N. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.12.053 · Cited by 222
Safety and efficacy of carvedilol in severe heart failure
Cohn, J. N., Fowler, M. B., Bristow, M. R., Colucci, W. S., Gilbert, E. M., Kinhal, V., Krueger, S. K., Lejemtel, T., Narahara, K. A., Packer, M., et al. (1997) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(97)90013-0 · Cited by 221
(1995) · Circulation · doi:10.1161/01.cir.92.2.212 · Cited by 210
Lechat, P., Escolano, S., Golmard, J. L., Lardoux, H., Witchitz, S., Henneman, J. A., Maisch, B., Hetzel, M., Jaillon, P., Boissel, J.-P., et al. (1997) · Circulation · doi:10.1161/01.cir.96.7.2197 · Cited by 206
Book ReviewNeuroanatomy: An atlas of structures, sections and systems
O'Rahilly, R. (1987) · New England Journal of Medicine · doi:10.1056/nejm198710223171718 · Cited by 197
Cicoira, M., Zanolla, L., Rossi, A., Golia, G., Franceschini, L., Brighetti, G., Marino, P., & Zardini, P. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01965-4 · Cited by 194
Nonpharmacologic Therapy Improves Functional and Emotional Status in Congestive Heart Failure
Kostis, J. B., Rosen, R. C., Cosgrove, N. M., Shindler, D. M., & Wilson, A. C. (1994) · Chest · doi:10.1378/chest.106.4.996 · Cited by 185
White, M., Yusuf, S., McKelvie, R. S., Pericak, D., Young, J. B., Latini, R., Pogue, J., Burns, R. J., Probstfield, J. L., Tsuyuki, R. T., et al. (2000) · Circulation · Cited by 183
Long-term therapy of heart failure with prazosin: A randomized double blind trial
Colucci, W. S., Wynne, J., Holman, B. L., & Braunwald, E. (1980) · The American Journal of Cardiology · doi:10.1016/0002-9149(80)90656-6 · Cited by 182
Hori, M., Sasayama, S., Kitabatake, A., Toyo-oka, T., Handa, S., Yokoyama, M., Matsuzaki, M., Takeshita, A., Origasa, H., Matsui, K., et al. (2004) · American Heart Journal · doi:10.1016/j.ahj.2003.07.023 · Cited by 166
Udelson, J. E., McGrew, F. A., Flores, E., Ibrahim, H., Katz, S., Koshkarian, G. M., O’Brien, T. X., Kronenberg, M. W., Zimmer, C., Orlandi, C., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.01.091 · Cited by 165
Self-citationBasu, S., Senior, R., Raval, U., van der Does, R., Bruckner, T. M., & Lahiri, A. (1997) · Circulation · doi:10.1161/01.cir.96.1.183 · Cited by 156
Surrogate end points in heart failure
Anand, I. S., Florea, V. G., & Fisher, L. D. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01773-4 · Cited by 153
Lenarda, A. D. (2000) · PubMed · Cited by 136
Franciosa, J. A., Wilen, M. M., & Jordan, R. A. (1985) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(85)80090-5 · Cited by 123
Packer, M., The Principal Investigators of the Reflect Study, Narahara, K. A., Elkayam, U., Sullivan, J. M., Pearle, D. L., Massie, B. M., & Creager, M. A. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90816-j · Cited by 119
Duncan, A. (2003) · European Heart Journal · doi:10.1016/s0195-668x(02)00475-x · Cited by 118
Levine, T. B., Bernink, P. J. L. M., Caspi, A., Elkayam, U., Geltman, E. M., Greenberg, B., McKenna, W. J., Ghali, J. K., Giles, T. D., Marmor, A. T., et al. (2000) · Circulation · doi:10.1161/01.cir.101.7.758 · Cited by 116
Ventricular remodeling in heart failure: a credible surrogate endpoint
Konstam, M. A., Udelson, J. E., Anand, I. S., & Cohn, J. N. (2003) · Journal of Cardiac Failure · doi:10.1054/j.cardfail.2003.09.001 · Cited by 111
Self-citationSwedberg, K. B., Bristow, M. R., Cohn, J. N., Dargie, H., Straub, M., Wiltse, C. G., & Wright, T. J. (2002) · Circulation · doi:10.1161/01.cir.0000014212.04920.62 · Cited by 109
Usefulness of bucindolol in congestive heart failure
Pollock, S. G., Lystash, J. C., Tedesco, C. L., Craddock, G. B., & Smucker, M. L. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90488-m · Cited by 107
Krum, H., Gu, A., Wiltshire‐Clement, M., Sackner‐Bernstein, J., Goldsmith, R., Medina, N., Yushak, M., Miller, M., Packer, M., & Packer, M. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90363-4 · Cited by 92
Dubach, P., MYERS, J. N., Bonetti, P. O., Schertler, T., Froelicher, V. F., Wagner, D., Scheidegger, M. B., Stuber, M., Luechinger, R., Schwitter, J., et al. (2002) · American Heart Journal · doi:10.1067/mhj.2002.121269 · Cited by 90
Bellenger, N. G., Rajappan, K., Rahman, S. L., Lahiri, A., Raval, U., Webster, J., Murray, G. D., Coats, A. J. S., Cleland, J. G. F., & Pennell, D. J. (2004) · Heart · doi:10.1136/hrt.2003.015552 · Cited by 89
Udelson, J. E., & Konstam, M. A. (2002) · Journal of Cardiac Failure · doi:10.1054/jcaf.2002.129289 · Cited by 88
Self-citationLittler, W. A., & Sheridan, D. J. (1995) · Heart · doi:10.1136/hrt.73.5.428 · Cited by 84
Guazzi, M., Agostoni, P., Matturri, M., Pontone, G., & Guazzi, M. D. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70148-1 · Cited by 83
Cohn, J. N., Tam, S. W., Anand, I. S., Taylor, A. L., Sabolinski, M. L., & Worcel, M. (2007) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2007.03.001 · Cited by 77
Efficacy and Safety of Oral Candesartan Cilexetil in Patients with Congestive Heart Failure
Matsumori, A. (2003) · European Journal of Heart Failure · doi:10.1016/s1388-9842(03)00162-4 · Cited by 77
Navarro‐López, F., Cosín, J., Marrugat, J., Guindo, J., de Luna, A. B., & The SSSD Investigators (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90291-j · Cited by 76
van Gilst, W. H., Kingma, J. H., Peels, K. H., Dambrink, J. E., & Sutton, M. S. J. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)00113-1 · Cited by 74
Early treatment with captopril after acute myocardial infarction.
Ray, S. G., Pye, M. P., Oldroyd, K. G., Christie, J. H., Connelly, D. T., Northridge, D. B., Ford, I., Morton, J. J., Dargie, H. J., & Cobbe, S. M. (1993) · Heart · doi:10.1136/hrt.69.3.215 · Cited by 63
Effects of captopril on ischemia and dysfunction of the left ventricle after myocardial infarction.
Søgaard, P., Gøtzsche, C.-O., Ravkilde, J., & Thygesen, K. A. (1993) · Circulation · doi:10.1161/01.cir.87.4.1093 · Cited by 59
Oral enoximone therapy in chronic heart failure: A placebo-controlled randomized trial
Narahara, K. A. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90154-a · Cited by 56
Udelson, J. E., DeAbate, C. A., Berk, M. R., Neuberg, G. W., Packer, M., Vijay, N. K., Gorwitt, J. K., Smith, W. B., Kukin, M. L., LeJemtel, T. H., et al. (2000) · American Heart Journal · doi:10.1016/s0002-8703(00)90095-4 · Cited by 51
Self-citationde Milliano, P. A. R., de Groot, A. C., Tijssen, J. G. P., van Eck‐Smit, B. L. F., van Zwieten, P. A., & Lie, K. I. (2002) · American Heart Journal · doi:10.1067/mhj.2002.121807 · Cited by 49
Goldstein, S., Kennedy, H. L., Hall, C., Anderson, J. L., Gheorghiade, M., Gottlieb, S. S., Jessup, M. L., Karlsberg, R. P., Friday, G. H., & Haskell, L. P. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70083-9 · Cited by 46
Kassis, E., & Amtorp, O. (1990) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199003000-00001 · Cited by 44
Tatlı, E., & Kürüm, T. (2005) · PubMed · Cited by 43
Left Ventricular Diastolic Function Improvement by Carvedilol Therapy in Advanced Heart Failure
Palazzuoli, A., Quatrini, I., Vecchiato, L., Calabria, P., Gennari, L., Martini, G., & Nuti, R. (2005) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000159880.12067.34 · Cited by 37
Choraria, S., Taylor, D. J. F., & Pilcher, J. F. (1987) · Circulation · doi:10.1161/01.cir.76.6.1307 · Cited by 34
Solal, A. C., Jondeau, G., Beauvais, F., & Berdeaux, A. (2004) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2003.12.007 · Cited by 31
Clinical Features and Outcome of Patients with Apical Hypertrophic Cardiomyopathy in Taiwan
Lee, C., Liu, P., Lin, L.-J., Chen, J.-H., & Tsai, L.-M. (2006) · Cardiology · doi:10.1159/000092590 · Cited by 26
A double-blind dose response comparison of oral enoximone and placebo for congestive heart failure
Zipperle, G., Butzer, F., Dieterich, H. A., & Heinrich, F. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)90530-3 · Cited by 23
Webster, M. W. I., Fitzpatrick, M. A., Hamilton, E. J., Nicholls, M. G., Ikram, H., Espiner, E. A., & Wells, J. E. (1985) · Drugs · doi:10.2165/00003495-198500301-00011 · Cited by 18
Chronic vasodilator therapy with flosequinan in congestive heart failure
Hass, G., BINKLEY, P., & Leier, C. V. (1990) · Clinical Cardiology · doi:10.1002/clc.4960130609 · Cited by 12
Cited by
Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation
Goldstein, D., Moskowitz, A. J., Gelijns, A. C., Ailawadi, G., Parides, M. K., Perrault, L. P., Hung, J. W., Voisine, P., Dagenais, F., Gillinov, A. M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1512913 · Cited by 972
Mitral-Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation
Acker, M. A., Parides, M. K., Perrault, L. P., Moskowitz, A. J., Gelijns, A. C., Voisine, P., Smith, P. K., Hung, J. W., Blackstone, E. H., Puskas, J. D., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312808 · Cited by 947
Left Ventricular Remodeling in Heart Failure
Konstam, M. A., Kramer, D. G., Patel, A. R., Maron, M. S., & Udelson, J. E. (2011) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2010.10.008 · Cited by 765
Self-citationCardiac myosin activation with omecamtiv mecarbil in systolic heart failure
Teerlink, J. R., Diaz, R., Felker, G. M., McMurray, J. J. V., Metra, M., Solomon, S. D., Adams, K. F., Anand, I., Arias-Mendoza, A., Biering-Sørensen, T., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2025797 · Cited by 656
Januzzi, J. L., Prescott, M. F., Butler, J., Felker, G. M., Maisel, A. S., McCague, K., Camacho, A., Piña, I. L., Rocha, R. A., Shah, A. M., et al. (2019) · JAMA · doi:10.1001/jama.2019.12821 · Cited by 634
Metadata
- Authors
- Kramer, D. G., Trikalinos, T. A., Kent, D. M., Antonopoulos, G. V., Konstam, M. A., & Udelson, J. E.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2010-07
- Volume
- 56
- Issue
- 5
- Pages
- 392-406
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W86846889
- Cited by
- 492
- References
- 136
- FWCI
- 7.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.